F. Raffi

430 total citations
20 papers, 204 citations indexed

About

F. Raffi is a scholar working on Emergency Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, F. Raffi has authored 20 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Emergency Medicine, 9 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in F. Raffi's work include HIV-related health complications and treatments (9 papers), HIV Research and Treatment (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). F. Raffi is often cited by papers focused on HIV-related health complications and treatments (9 papers), HIV Research and Treatment (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). F. Raffi collaborates with scholars based in France, Canada and Martinique. F. Raffi's co-authors include Clotilde Allavena, Lise Cuzin, Eric Billaud, Cyrille Delpierre, Pascale V. Guillot, Claudine Duvivier, N. Viget, Jacques Bernard, D. Rey and Firouzé Bani‐Sadr and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Alimentary Pharmacology & Therapeutics.

In The Last Decade

F. Raffi

18 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Raffi France 8 113 79 55 50 35 20 204
Miguel Cervero Spain 9 87 0.8× 191 2.4× 135 2.5× 70 1.4× 34 1.0× 44 325
Tanakorn Apornpong Thailand 10 129 1.1× 134 1.7× 152 2.8× 23 0.5× 130 3.7× 40 344
Livia Giner Spain 8 71 0.6× 81 1.0× 77 1.4× 14 0.3× 69 2.0× 13 191
Anja Potthoff Germany 10 150 1.3× 69 0.9× 72 1.3× 11 0.2× 37 1.1× 24 249
Sirintip Sricharoenchai Thailand 8 60 0.5× 70 0.9× 84 1.5× 7 0.1× 32 0.9× 14 183
P. Morlat France 6 142 1.3× 130 1.6× 59 1.1× 10 0.2× 77 2.2× 15 246
Montserrat Sala Spain 9 102 0.9× 137 1.7× 102 1.9× 8 0.2× 72 2.1× 16 340
Jennifer Rothenberg United States 3 226 2.0× 109 1.4× 32 0.6× 32 0.6× 87 2.5× 4 253
Michael Basar United States 6 204 1.8× 211 2.7× 61 1.1× 8 0.2× 149 4.3× 8 334
JM Miró Spain 8 84 0.7× 199 2.5× 135 2.5× 6 0.1× 118 3.4× 14 355

Countries citing papers authored by F. Raffi

Since Specialization
Citations

This map shows the geographic impact of F. Raffi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Raffi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Raffi more than expected).

Fields of papers citing papers by F. Raffi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Raffi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Raffi. The network helps show where F. Raffi may publish in the future.

Co-authorship network of co-authors of F. Raffi

This figure shows the co-authorship network connecting the top 25 collaborators of F. Raffi. A scholar is included among the top collaborators of F. Raffi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Raffi. F. Raffi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabié, André, Cyrille Delpierre, P. Puglièse, et al.. (2021). Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort. Public Health. 196. 129–134. 3 indexed citations
2.
Bernaud, C., Christophe Michau, Philippe Van de Perre, et al.. (2019). HIV-infected patients aged above 75 years. Médecine et Maladies Infectieuses. 50(1). 43–48. 9 indexed citations
3.
Bastard, J.-P., Camille Couffignal, Soraya Fellahi, et al.. (2019). Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients. Diabetes & Metabolism. 45(6). 573–581. 19 indexed citations
4.
Provoost, A. P., Moustapha Dramé, Laurent Cotte, et al.. (2018). Risk of diabetes inHIV‐infected patients is associated with cirrhosis but not with chronicHCVcoinfection in a French nationwideHIVcohort. Alimentary Pharmacology & Therapeutics. 48(3). 281–289. 3 indexed citations
5.
Allavena, Clotilde, Cyrille Delpierre, Lise Cuzin, et al.. (2012). High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. Journal of Antimicrobial Chemotherapy. 67(9). 2222–2230. 62 indexed citations
6.
Jackson, Akil, Clotilde Allavena, F. Raffi, et al.. (2011). Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients. HIV Medicine. 12(10). 620–631. 28 indexed citations
7.
Biron, Charlotte, Christine Bobin‐Dubigeon, C. Leport, et al.. (2008). N-13 Syndrome métabolique chez les patients VIH+ sous HAART depuis 1 an à 4 ans : étude SYMET. Médecine et Maladies Infectieuses. 38. S172–S172.
8.
Préau, Marie, Anne‐Déborah Bouhnik, Bruno Spire, et al.. (2006). Qualité de vie et syndrome lipodystrophique chez les patients infectés par le VIH. L Encéphale. 32(5). 713–719. 10 indexed citations
9.
Moing, Vincent Le, Christian Rabaud, Valérie Journot, et al.. (2006). Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV‐infected patients started on a protease inhibitor‐containing regimen. HIV Medicine. 7(4). 261–267. 27 indexed citations
10.
Léautez, S, et al.. (2002). Méningite à Streptococcus salivarius avec bactériémie révélant un cholestéatome de l'apex petreux. Médecine et Maladies Infectieuses. 32(1). 49–51. 2 indexed citations
11.
Léautez, S, et al.. (2001). [Pulmonary hypertension in HIV-infected patients].. PubMed. 18(4 Pt 1). 432–5. 3 indexed citations
12.
Raffi, F.. (2000). [Resistance to protease inhibitors: the role of the MDR gene].. PubMed. 29(37). 2036–7. 2 indexed citations
13.
Barrier, J, Firouzé Bani‐Sadr, Fanny Gaillard, & F. Raffi. (1997). Spontaneous Rupture of the Spleen Revealing Primary Human Immunodeficiency Virus Infection. Clinical Infectious Diseases. 25(2). 336–337. 14 indexed citations
14.
Magadur-Joly, G, et al.. (1996). [Hematogenic bacterial endophthalmitis. A rare infection with very poor functional prognosis].. PubMed. 147(3). 212–7. 3 indexed citations
15.
Tiab, Mourad, F. Raffi, M. Hamidou, Bénédicte Dupas, & J Barrier. (1995). [Paralysis of the 3d cranial nerve disclosing primary cytomegalovirus infection in an immunocompetent adult].. PubMed. 146(2). 130–2. 1 indexed citations
16.
Bani‐Sadr, Firouzé, et al.. (1995). [Clinical and bacteriological aspects of nocardiasis. 9 cases].. PubMed. 24(23). 1062–6. 9 indexed citations
17.
Leport, C., P Ambroise-Thomas, Geneviève Chêne, et al.. (1993). [Update on consensual proposals (1993 February). Role of cotrimoxazole in the primary prevention of toxoplasmosis in patients with HIV infection].. PubMed. 144(1). 56–7.
18.
Raffi, F. & Philippe Patra. (1991). [Infected aneurysms of the aorta].. PubMed. 41(19). 1785–8. 5 indexed citations
19.
Raffi, F., et al.. (1986). [Infected arterial aneurysms. Anatomo-clinical and surgical aspects apropos of 12 cases].. PubMed. 123(11). 654–62. 3 indexed citations
20.
Barrier, J, F. Gaillard, Maryse Fiche, et al.. (1983). Rupture splénique spontanée au cours d'une varicelle chez un adulte non immunodéprimé. Médecine et Maladies Infectieuses. 13(11). 775–777. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Cervero Breakdown of academic impact, for papers by Tanakorn Apornpong Breakdown of academic impact, for papers by Livia Giner Breakdown of academic impact, for papers by Anja Potthoff Breakdown of academic impact, for papers by Sirintip Sricharoenchai Breakdown of academic impact, for papers by P. Morlat Breakdown of academic impact, for papers by Montserrat Sala Breakdown of academic impact, for papers by Jennifer Rothenberg Breakdown of academic impact, for papers by Michael Basar Breakdown of academic impact, for papers by JM Miró
Rankless by CCL
2026